Interpace Biosciences, Inc. (IDXG)

USD 2.41

(-9.06%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 13.02 Million 15.97 Million 38.42 Million 45.68 Million 69.05 Million 48.44 Million
Total Current Assets 10.32 Million 12.15 Million 12.16 Million 14.12 Million 16.36 Million 17.72 Million
Cash And Short Term Investments 3.49 Million 4.82 Million 3.31 Million 2.77 Million 2.32 Million 6.06 Million
Cash and Cash Equivalents 3.49 Million 4.82 Million 3.31 Million 2.77 Million 2.32 Million 6.06 Million
Short Term Investments - - - - - -
Net Receivables 4.98 Million 5.03 Million 6.15 Million 8.02 Million 10.19 Million 9.48 Million
Inventory 1.22 Million 1.22 Million 1.78 Million 2.05 Million 1.82 Million 1.23 Million
Other Current Assets 614 Thousand 180 Thousand 108 Thousand 45 Thousand 167 Thousand 940 Thousand
Total Non-Current Assets 2.69 Million 3.82 Million 26.26 Million 31.55 Million 52.68 Million 30.72 Million
Net PPE 2.65 Million 2.91 Million 10.38 Million 11.73 Million 10.7 Million 837 Thousand
Good Will And Intangible Assets - 861 Thousand 15.72 Million 19.78 Million 41.93 Million 29.85 Million
Good Will - - 8.43 Million 8.43 Million 8.43 Million -
Intangible Assets - 861 Thousand 7.28 Million 11.35 Million 33.5 Million 29.85 Million
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets 45 Thousand 45 Thousand 160 Thousand 42 Thousand 42 Thousand 31 Thousand
Other Assets - - - - - -
Total Liabilities 28.15 Million 79.05 Million 80.84 Million 74.76 Million 56.02 Million 15.5 Million
Total Current Liabilities 17.47 Million 14.28 Million 15.68 Million 18.23 Million 17.29 Million 8.49 Million
Account Payables 1.54 Million 1.05 Million 2.69 Million 4.51 Million 4.81 Million 1.05 Million
Tax Payables 261 Thousand 262 Thousand 245 Thousand 334 Thousand 403 Thousand 285 Thousand
Short Term Debt 5.47 Million 3.07 Million 1.12 Million 1.2 Million 1.5 Million -
Deferred Revenue 261 Thousand - 40 Thousand 54 Thousand 457 Thousand -
Other Current Liabilities 10.19 Million 10.15 Million 11.82 Million 12.46 Million 10.52 Million 7.43 Million
Total Non Current Liabilities 10.68 Million 64.76 Million 65.16 Million 56.53 Million 38.72 Million 7.01 Million
Long-Term Debt 4.24 Million 13.01 Million 12.59 Million 3.54 Million 5.59 Million -
Deferred Revenue Non Current - - 13 Thousand 136 Thousand 269 Thousand -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 6.44 Million 51.75 Million 6.01 Million 48.51 Million 28.78 Million 3.17 Million
Other Liabilities - - - - - -
Total Equity -15.13 Million -63.07 Million -42.41 Million -29.08 Million 13.02 Million 32.93 Million
Stock Holders Equity -15.13 Million -63.07 Million -42.41 Million -29.08 Million 13.02 Million 32.93 Million
Common Stock 405 Thousand 405 Thousand 403 Thousand 402 Thousand 393 Thousand 287 Thousand
Retained Earnings -248.21 Million -249.01 Million -227.05 Million -212.11 Million -168.16 Million -141.48 Million
Accumulated other comprehensive income -46.53 Million - - -45.68 Million -26.17 Million -1.37 Million
Common Stock Equity -15.13 Million -63.07 Million -42.41 Million -29.08 Million 13.02 Million 32.93 Million
Capital Lease Obligation 1.47 Million 2.42 Million 4.27 Million 4.74 Million 4.09 Million -
Total Investments - - - - - -
Total Debt 11.19 Million 16.09 Million 13.71 Million 4.74 Million 7.09 Million -
Net Debt 7.69 Million 11.26 Million 10.4 Million 1.97 Million 4.77 Million -6.06 Million

Balance Sheet Charts